Postprandial Glycemic and Physiological Responses to Walking With a Wearable Hip Exoskeleton in Healthy Adults
Bot-Fit Health
3 other identifiers
interventional
22
1 country
1
Brief Summary
This randomized crossover proof-of-concept study evaluated the effects of walking with a wearable hip exoskeleton on postprandial glycemic and physiological responses in healthy adults. Participants completed four experimental conditions: seated control, walking without the wearable hip exoskeleton, walking with the Bot-Fit device in Aqua mode, and walking with the Bot-Fit device in Boost mode. The primary aim was to determine whether walking with the wearable hip exoskeleton alters postprandial glucose responses compared with seated control and conventional walking conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 25, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 25, 2026
CompletedFirst Submitted
Initial submission to the registry
July 5, 2026
CompletedFirst Posted
Study publicly available on registry
July 10, 2026
CompletedJuly 10, 2026
July 1, 2026
1 month
July 5, 2026
July 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incremental Area Under the Curve for Postprandial Glucose
Incremental area under the curve for postprandial glucose was calculated during the postprandial measurement period for each experimental condition.
Up to 120 minutes after meal ingestion during each experimental trial
Secondary Outcomes (3)
Peak Postprandial Glucose Concentration
Up to 120 minutes after meal ingestion during each experimental trial
Heart Rate Response
From the start to the end of the 30-minute intervention or control period on each experimental trial day
Rating of Perceived Exertion
Immediately after each experimental condition
Study Arms (4)
Seated Control
NO INTERVENTIONParticipants remained seated during the postprandial period without walking or wearable hip exoskeleton assistance.
Walking Without Bot-Fit
ACTIVE COMPARATORParticipants performed walking without wearing the Bot-Fit wearable hip exoskeleton.
Bot-Fit Aqua Mode
EXPERIMENTALParticipants performed walking while wearing the Bot-Fit wearable hip exoskeleton in Aqua mode.
Bot-Fit Boost Mode
EXPERIMENTALParticipants performed walking while wearing the Bot-Fit wearable hip exoskeleton in Boost mode.
Interventions
Participants performed walking without wearing the Bot-Fit wearable hip exoskeleton during the postprandial period.
Participants performed walking while wearing the Bot-Fit wearable hip exoskeleton in Aqua mode during the postprandial period.
Participants performed walking while wearing the Bot-Fit wearable hip exoskeleton in Boost mode during the postprandial period.
Eligibility Criteria
You may qualify if:
- Healthy adults aged 20 to 65 years.
- Participants who were able to complete walking trials with and without the wearable hip exoskeleton.
- Participants who provided written informed consent before participation.
You may not qualify if:
- Participants with diagnosed metabolic, cardiovascular, neurological, or musculoskeletal disorders.
- Participants with conditions that could affect walking ability or safe use of the wearable hip exoskeleton.
- Participants taking medications known to affect glucose metabolism.
- Participants who were unable to comply with the study procedures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CHA Universitylead
- Samsung Electronicscollaborator
Study Sites (1)
CHA University
Seongnam-si, Gyeonggi-do, 13503, South Korea
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Seung-Bo Park, Ph.D
CHA University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 5, 2026
First Posted
July 10, 2026
Study Start
March 17, 2026
Primary Completion
April 25, 2026
Study Completion
April 25, 2026
Last Updated
July 10, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Data may be made available after publication of the main study results and will be available for a reasonable period thereafter.
- Access Criteria
- Data may be shared with qualified researchers who submit a reasonable research proposal to the corresponding author. Access will be granted only after review and approval by the investigators and, where required, appropriate institutional or ethics committee approval. Data will be shared only for scientific purposes and in a deidentified form.
Deidentified individual participant data underlying the main results of the study may be shared upon reasonable request. The shared data may include postprandial glucose responses, heart rate, rating of perceived exertion, and relevant demographic and physiological variables after deidentification.